(Allergan plc)

	AGN latest price $183.0819 (-0.36%) ($182.3387 - $184.5876) on Fri. Dec. 2, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.21% (three month average)
RSI	29
Latest Price	$183.0819(-0.36%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -2.1% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(44%)    SPY(43%)    ARKG(42%)
Factors Impacting AGN price	AGN will decline at least -1.105% in a week (0% probabilities).   VIXM(-29%)    TLT(-15%)    UUP(-14%)    SHY(-3%)    IPO(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.105% (StdDev 2.21%)
Hourly BBV	0 ()
Intraday Trend	-0.2%

1 - 5 Day Possible Target	$179.07(-2.19%)
Resistance Level	$189.62
5 Day Moving Average	$184.73(-0.89%)
10 Day Moving Average	$184.74(-0.9%)
20 Day Moving Average	$189.62(-3.45%)
To recent high	-23%
To recent low	0.5%
Market Cap	$60.362b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed